Phage-encoded combinatorial chemical libraries based on bicyclic peptides

Nature Chemical Biology

Volumn 5, Issue 7, 2009, Pages 502-507

  Heinis, Christian ^a,c   Rutherford, Trevor ^b   Freund, Stephan ^b   Winter, Greg ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIMETHYLBENZENE; AMINO ACID; BACTERIAL PROTEIN; BENZENE; CYSTEINE; KALLIKREIN; TRIS (BROMOMETHYL)BENZENE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL GENE; BACTERIOPHAGE; BACTERIUM CONJUGATION; BINDING AFFINITY; BLOOD CLOTTING; BLOOD SAMPLING; EX VIVO STUDY; GENE LIBRARY; GENETIC CODE; MOLECULAR CLONING; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN STRUCTURE; PROTEIN SYNTHESIS;

EID: 67650305952     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.184     Document Type: Article

References (45)

1. Bleicher, K.H., Bohm, H.J., Muller, K. & Alanine, A.I. Hit and lead generation: beyond high-throughput screening. Nat. Rev. Drug Discov. 2, 369-378 (2003).
2. Hüser, J. High-Throughput Screening in Drug Discovery Vol. 35 (Wiley-VCH, Weinheim, Germany, 2006).
3. Huse, W.D. et al. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 246, 1275-1281 (1989).
4. Ward, E.S., Gussow, D., Griffiths, A.D., Jones, P.T. & Winter, G. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 341, 544-546 (1989).
5. McCafferty, J., Griffiths, A.D., Winter, G. & Chiswell, D.J. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552-554 (1990).
6. Scott, J.K. & Smith, G.P. Searching for peptide ligands with an epitope library. Science 249, 386-390 (1990).
7. Marks, J.D., Hoogenboom, H.R., Griffiths, A.D. & Winter, G. Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system. J. Biol. Chem. 267, 16007-16010 (1992).
8. Lipovsek, D. & Pluckthun, A. In-vitro protein evolution by ribosome display and mRNA display. J. Immunol. Methods 290, 51-67 (2004).
9. Ulrich, H. DNA and RNA aptamers as modulators of protein function. Med. Chem. 1, 199-208 (2005).
10. Barbas, C.F, III. Synthetic human antibodies. Nat. Med. 1, 837-839 (1995).
11. Holliger, P. & Hudson, P.J. Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23, 1126-1136 (2005).
12. Lerner, R.A. Manufacturing immunity to disease in a test tube: the magic bullet realized. Angew. Chem. Int. Edn Engl. 45, 8106-8125 (2006).
13. Nygren, P.A. & Skerra, A. Binding proteins from alternative scaffolds. J. Immunol. Methods 290, 3-28 (2004).
14. Doyon, J.B., Snyder, T.M. & Liu, D.R. Highly sensitive in vitro selections for DNA-linked synthetic small molecules with protein binding affinity and specificity. J. Am. Chem. Soc. 125, 12372-12373 (2003).
15. Melkko, S., Scheuermann, J., Dumelin, C.E. & Neri, D. Encoded self-assembling chemical libraries. Nat. Biotechnol. 22, 568-574 (2004).
16. Mannocci, L. et al. High-throughput sequencing allows the identification of binding molecules isolated from DNA-encoded chemical libraries. Proc. Natl. Acad. Sci. USA 105, 17670-17675 (2008).
17. Woiwode, T.F. et al. Synthetic compound libraries displayed on the surface of encoded bacteriophage. Chem. Biol. 10, 847-858 (2003).
18. Brenner, S. & Lerner, R.A. Encoded combinatorial chemistry. Proc. Natl. Acad. Sci. USA 89, 5381-5383 (1992).
19. Gartner, Z.J. et al. DNA-templated organic synthesis and selection of a library of macrocycles. Science 305, 1601-1605 (2004).
20. Halpin, D.R. & Harbury, P.B. DNA display II. Genetic manipulation of combinatorial chemistry libraries for small-molecule evolution. PLoS Biol. 2, E174 (2004).
21. Tse, B.N., Snyder, T.M., Shen, Y. & Liu, D.R. Translation of DNA into a library of 13,000 synthetic small-molecule macrocycles suitable for in vitro selection. J. Am. Chem. Soc. 130, 15611-15626 (2008).
22. Kemp, D.S. & McNamara, P.E. Conformationally restricted cyclic nonapeptides derived from L-cysteine and LL-3-amino-2-piperidino-6-carboxylic acid (LL-acp), a potent b-turn-inducing dipeptide analogue. J. Org. Chem. 50, 5834-5838 (1985).
23. Timmerman, P., Beld, J., Meloen, R.H. & Puijk, W.C. Method for selecting a candidate drug compound. WO patent 2004077062 (2004).
24. Timmerman, P., Beld, J., Puijk, W.C. & Meloen, R.H. Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces. ChemBioChem 6, 821-824 (2005).
25. Timmerman, P., Puijk, W.C, Slootstra, J.W., Van Dijk, E. & Meloen, R.H. Binding compounds, immunogenic compounds and peptidomimetics. WO patent 2006078161 (2006).
26. Jespers, L.S.A., Winter, G.P., Bonnert, T.P. & Simon, T.M. SBP members with a chemical moiety covalently bound within the binding site. WO patent 9501438 (1995).
27. Jespers, L, Bonnert, T.P. & Winter, G. Selection of optical biosensors from chemisyn-thetic antibody libraries. Protein Eng. Des. Sel. 17, 709-713 (2004).
28. Wessjohann, L.A., Ruijter, E., Garcia-Rivera, D. & Brandt, W. What can a chemist learn from nature's macrocycles?-a brief, conceptual view. Mol. Divers. 9, 171-186 (2005).
29. Driggers, E.M., Hale, S.P., Lee, J. & Terrett, N.K. The exploration of macrocycles for drugdiscovery-an underexploited structural class. Nat. Rev. DrugDiscov. 7, 608-624 (2008).
30. Kather, I., Bippes, C.A. & Schmid, F.X. A stable disulfide-freegene- 3-protein of phage fd generated by in vitro evolution. J. Mol. Biol. 354, 666-678 (2005).
31. Cheng, Y. & Prusoff, W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108 (1973).
32. Abbenante, G. & Fairlie, D.P. Protease inhibitors in the clinic. Med. Chem. 1, 71-104 (2005).
33. Turk, B. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug Discov. 5, 785-799 (2006).
34. Millward, S.W., Fiacco, S., Austin, R.J. & Roberts, R.W. Design of cyclic peptides that bind protein surfaces with antibody-like affinity. ACS Chem. Biol. 2, 625-634 (2007).
35. Litovchick, A. & Szostak, J.W. Selection of cyclic peptide aptamers to HCV IRES RNA using mRNA display. Proc. Natl. Acad. Sci. USA 105, 15293-15298 (2008).
36. Cremlyn, R.J. An Introduction to Organosulfur Chemistry 1st edn. (Wiley, Chichester, UK, 1996).
37. Wood, S.P. et al. Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. Science 232, 633-636 (1986).
38. Bhaskaran, R., Chuang, L.C. & Yu, C. Conformational properties of oxytocin in dimethyl sulfoxide solution: NMR and restrained molecular dynamics studies. Biopolymers 32, 1599-1608 (1992).
39. Pohl, E. et al. Structure of octreotide, a somatostatin analogue. Acta Crystallogr. D Biol. Crystallogr. 51, 48-59 (1995).
40. Melacini, G., Zhu, Q. & Goodman, M. Multiconformational NMR analysis of sandos-tatin (octreotide): equilibrium between beta-sheet and partially helical structures. Biochemistry 36, 1233-1241 (1997).
41. Jackson, D.Y et al. A designed peptide ligase for total synthesis of ribonuclease A with unnatural catalytic residues. Science 266, 243-247 (1994).
42. Sandman, K.E. & Noren, C.J. The efficiency of Escherichia coli selenocysteine insertion is influenced by the immediate downstream nucleotide. Nucleic Acids Res. 28, 755-761 (2000).
43. Sandman, K.E., Benner, J.S. & Noren, C.J. Phage display of selenopeptides. J. Am. Chem. Soc. 122, 960-961 (2000).
44. Dennis, M.S. et al. Peptide exosite inhibitors of factor VIIa as anticoagulants. Nature 404, 465-470 (2000).
45. Huang, L. et al. Novel peptide inhibitors of angiotensin- converting enzyme 2. J. Biol. Chem. 278, 15532-15540 (2003).